NeRRe Therapeutics
UKEntry
2021
Hold
5yr
Status
Active
Who owns NeRRe Therapeutics?
NeRRe Therapeutics is currently owned by Columbus Venture Partners through Columbus Life Science Fund II (2019 vintage), since 2021. Across its history, NeRRe Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-08-09
Most recent investor
Columbus Venture PartnersColumbus Life Science Fund II · 2019 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQUnited Kingdom
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
Novo HoldingsActive
2021 · present(5yr) · Novo Holdings Venture Investments · 1999 · VC
More from Columbus Life Science Fund II
Other portfolio companies in the same fund.
Minoryx Therapeutics
Active
Biotech
Spain· 2022
Spain· 2022Highlight Therapeutics
Active
BiotechSpain· 2020
Spain· 2020RECOVID Solutions
Exited 2022
HealthTechSpain· 2020
Spain· 2020to
Sanifit Therapeutics
Exited 2021
BiotechSpain· 2019
Spain· 2019to
Viralgen Commercial
Exited 2021
BiotechSpain· 2019
Spain· 2019to
Radioterapia de Protones
Exited 2024
HealthcareSpain· 2017
Spain· 2017to
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack NeRRe Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy NeRRe Therapeutics?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on NeRRe Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue